At present, “we do not foresee any significant new risk factors; however, sentiment remains subdued,” Vikas Gupta, CEO and Chief Investment Strategist at OmniScience Capital said in an interview to Moneycontrol.
According to him, Q4FY25 earnings are expected to remain muted. However, he anticipates a strong earnings recovery starting from H2FY26, possibly as early as Q2FY26.
In the recent correction, “we have focused on acquiring banks with the low